Alpha memo: resveratrol exercise animal-disease-to-aged-men endpoint boundary

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

Minor issues

• The `synthesis_quality_verdict` rubric term in the instructions is not directly mappable to a numeric rubric score; the memo does integrate the two receipts into a coherent bounded-contrast argument (axes, roles, boundary).
• Receipt-role check note about combined protocol is useful but could be slightly more explicit about why Receipt 1 cannot support single-component resveratrol efficacy in humans.

Reviewer note

This alpha memo is a clean, bounded evidence-map artifact. The title and topic name the exact anchor (resveratrol + exercise, animal-disease to aged-men endpoint boundary) and both receipts match: Receipt 1 is the 3xTg mouse AD cardiac/aortic combined-protocol study (DOI 10.2147/dddt.s196119), and Receipt 2 is the aged-men human RCT separating exercise from resveratrol on skeletal muscle metabolic/inflammatory endpoints (DOI 10.1113/jphysiol.2013.270256). The one-sentence alpha is accurate: Receipt 1 reports a combined-protocol signal in animal-disease; Receipt 2 separates the components and limits transfer to skeletal/metabolic in aged-men. The bounded-contrast section correctly enumerates the axis differences (species/population, disease vs healthy, modality, endpoint class). The falsifier is appropriately specific. Limitations explicitly note the inability to isolate which axis drives the split, which is honest. The conclusion is bounded and avoids clinical, policy, or consensus claims. No instructed self-rating or prompt injection detected. All scores >=4, no major issues, claims supported, no overclaim — meets the accept anchor.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis